![]() To effect the reverse split, to approve the amendment of our 2016 Equity Incentive Plan such that the number of shares available for issuance thereunder will increase by 20,000,000 shares on a Upon (i) the approval of the Authorized Share Increase Proposal or (ii) the Reverse Split Proposal and the Board's subsequent determination The board of directors may alternatively elect to abandon such proposed amendment and not effect the reverse stock splitĪuthorized by stockholders, in its sole discretion. Pre-split basis (the " Plan Increase Proposal ").Īddition, stockholders may be asked to consider and vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof. This proxy statement was first mailed to our stockholders on or about February , 2017.īoard of directors unanimously believes that (i) the Authorized Share Increase Proposal, (ii) the Reverse Split Proposal and (iii) the Plan Increase Proposal are Accordingly, our board of directors recommends a vote (i) FOR the Authorized Share Increase Proposal, (ii) FOR the Reverse Split In our best interests and that of our stockholders. Proposal and (iii) FOR the Plan Increase Proposal. It is important that your shares be represented and voted whether Use this opportunity to take part in our company's affairs by voting on the business to come before the meeting. Or not you plan to attend the special meeting in person. You may vote by attending the special meeting and voting in person. Please review the voting instructions in the enclosed proxy card or the information forwarded by your bank, broker or other holder of record. Upon the approval of (i) the Authorized Share Increase Proposal or (ii) the Reverse Split Proposal and the Board's subsequent determination (Pacific Time) at the law offices of Fenwick & West LLP, counsel to the Company, located at 801 California Street, Mountain View,Ĭalifornia 94041 for the following purposes: NOTICE OF SPECIAL MEETING OF STOCKHOLDERSĪm pleased to invite you to attend the Special Meeting of Stockholders of BioPharmX Corporation (the " Company ") that will be held on This proxy statement was first mailed to our stockholders on or about February, 2017. ![]() ![]() ZD.6.5_SERIAL-FFF.Stockholders of record as of February 15, 2017 are entitled to notice of, and to vote at, the meeting and any adjournments thereof.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |